Interpreting Medical Necessity And Symptom Severity belongs in serious BCBA study because it shapes whether behavior-analytic decisions stay useful once they leave a clean training example and enter clinic sessions and day-to-day service delivery. In Interpreting Medical Necessity And Symptom Severity, for this course, the practical stakes show up in safe, humane intervention that respects health variables and daily-life feasibility, not in abstract discussion alone.
Provider: CASP CEU Center
Take This Course →Including ethics, supervision, and topics like this one. New live CEU every Wednesday.
Join Free →Interpreting Medical Necessity & Symptom Severity Conceptualizing Socially Valid Progress & Treatment Dosage Alignment Original Air Date: July 9, 2025 Short title: Interpreting Medical Necessity & Symptom Severity CEU offered: 1.0 BACB Learning CEU Webinar Duration: 60 minutes Instructors: Nicole McMillan, PhD, BCBA-D Allison Brazendale, PsyD Abstract: p.p1 {margin: 0.0px 0.0px 12.0px 0.0px; font: 12.0px Times; -webkit-text-stroke: #000000} li.li2 {margin: 0.0px 0.0px 0.0px 0.0px; font: 12.0px Times; -webkit-text-stroke: #000000} span.s1 {font-kerning: none} ol.ol1 {list-style-type: decimal} In the field of evaluation and diagnostics, there is currently no objective guide or decision-making tool that incorporates the DSM-5 available for a clinician to determine the diagnostic severity of Autism Spectrum Disorder (ASD) (i.e., levels 1, 2, 3) across raters. Similarly, in the field of ABA, there is no wide-scale industry standard for practitioners when recommending a treatment dosage for ABA therapy; treatment dosages are typically informed by a summation of subjective and objective assessments of the recipients of the ABA services with the ultimate determination being the clinical opinion of the practitioner. This lack of standardization across both diagnostics and treatment is a significant practice gap across both fields and leads to flawed diagnoses and medically necessary dosage recommendations. The presenters will discuss the definition of medical necessity in relation to insurance funders, industry guidelines, and the severity of diagnostic symptoms, particularly ASD, while drawing parallels to the broader healthcare industry. Content of the presentation will discuss the need for progress monitoring throughout a recipient's time in ABA services and how that relates to treatment dosages. The presenters will also review preliminary data associated with these topics. Learning Objectives Participants should be able to describe medical necessity in the fields
| Certification Body | Credits | Type |
|---|---|---|
| BACB | 1 | General |
Dig into the research behind this topic — plain-English summaries written for BCBAs.
258 research articles with practitioner takeaways
252 research articles with practitioner takeaways
233 research articles with practitioner takeaways
You earn CEUs from a dozen different places. Upload any certificate — from here, your employer, conferences, wherever — and always know exactly where you stand. Learning, Ethics, Supervision, all handled.
No credit card required. Cancel anytime.
All behavior-analytic intervention is individualized. The information on this page is for educational purposes and does not constitute clinical advice. Treatment decisions should be informed by the best available published research, individualized assessment, and obtained with the informed consent of the client or their legal guardian. Behavior analysts are responsible for practicing within the boundaries of their competence and adhering to the BACB Ethics Code for Behavior Analysts.